AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Investigational new drug applications filed for M-Vax, O-Vax.(AVAX Technologies Inc.)(Brief Article)
2002 NOV 7 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT) announced the submission of investigational new drug applications (IND) for M-Vax and O-Vax, its AC Vaccine technology product candidates for the treatment of melanoma and ovarian cancers, with the U.S. Food and Drug Administration (FDA).
If, after a 30-day review period FDA has no questions, the company will be able to commence its clinical trials.
David L. Tousley, president and chief operating officer of Avax stated, "This is an important milestone in the continuing development of the frozen AC Vaccine technology. Our team has done a great job in completing the necessary product development activities, assay development and facility and quality system modifications leading to the submission of these INDs and ensuring that we are ready to carry out the clinical trials."
The endpoints for these clinical trials are overall safety ...
- AVAX Technologies' AC Vaccine(TM) Improves Relapse-Free Survival In a Breast...
- Press release article from: PR Newswire April 5, 2000 700+ words
...PRNewswire/ -- AVAX Technologies, Inc. (Nasdaq...preclinical data on its AC Vaccine(TM) technology...amp; CEO of AVAX Technologies, stated, "These...potential of our AC Vaccine technology as...in 2000. The AC Vaccine technology is...breast cancer. ...
- AVAX Technologies' AC Vaccine(TM) Data Presented at Hadassah Medical Center In...
- Press release article from: PR Newswire October 26, 1999 700+ words
...Inventor of the AC Vaccine(TM) Technology...PRNewswire/ -- AVAX TECHNOLOGIES, INC. ("AVAX...inventor of the AC Vaccine(TM) technology...s proprietary AC Vaccine(TM) technology...United States. AVAX Technologies, Inc. specializes...
- AVAX Technologies and Neptunus International Holdings Limited Execute Joint...
- Press release article from: PR Newswire December 1, 1999 700+ words
...PRNewswire/ -- AVAX Technologies, Inc. (Nasdaq...cancer vaccine (AC Vaccine(TM)) for...and CEO of AVAX Technologies, Inc., stated...rate of 55%. AVAX Technologies, Inc. specializes...technologies: the AC Vaccine technology...
- AVAX Technologies and Neptunus International Holdings Limited Announce Joint...
- Press release article from: PR Newswire June 15, 1999 700+ words
...PRNewswire/ -- AVAX Technologies, Inc. (Nasdaq...Cell Vaccine (AC Vaccine(TM)) in...Autologous Cell (AC) Vaccine(TM) technology...President and CEO of AVAX Technologies, Inc., stated...commercialize our unique AC Vaccine technology outside...
- AVAX Technologies Announces Collaboration with the University of Pennsylvania...
- Press release article from: Business Wire February 22, 2005 700+ words
...submitted to AACR AVAX Technologies, Inc. (OTCMarket...clinical trial of its AC Vaccine in patients with...20%. About the AC Vaccine Therapeutic AVAX's AC Vaccine platform is a therapeutic...sixteen patients. AVAX Technologies, Inc. is a biotechnology...
- AVAX Technologies Announces Publication of Paper on the Anti-Metastatic...
- Press release article from: PR Newswire June 11, 2002 700+ words
...11 /PRNewswire-FirstCall/ -- AVAX Technologies, Inc. today announced the publication...the Company's hapten-modified AC Vaccine technology significantly improved...trials with the frozen vaccine." AVAX Technologies, Inc. specializes in the development...
- AVAX Technologies Receives an Additional $3.0 Million (AUD) Investment In...
- Press release article from: PR Newswire April 6, 2000 700+ words
...PRNewswire/ -- AVAX Technologies, Inc. (Nasdaq...manufacture and market AVAX Technologies' autologous cancer vaccine (AC Vaccine(TM)) for...the U.S. AVAX Technologies, Inc. specializes...technologies: the AC Vaccine technology...
- AVAX Technologies Announces Dr. David Berd Joins the Company as Chief Medical...
- Press release article from: Business Wire November 2, 2004 700+ words
...PHILADELPHIA -- AVAX Technologies, Inc. (OTCMarket...Autologous Cell (AC) Vaccine therapeutic platform...planned. About the AC Vaccine Therapeutic AVAX Technologies, Inc. is a biotechnology...companies. AVAX's AC Vaccine is a therapeutic...
Source: HighBeam Research, Investigational new drug applications filed for M-Vax, O-Vax.(AVAX...